Yali Z. Cao

Nanchang, CN 
Nanchang, CN 

Overview

Yali Cao practices practicing medicine in Nanchang, China.

Their clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Fibroadenoma, Breast Cancer in Men, and Mastectomy.

They are actively involved in clinical research, co-authoring 39 peer reviewed articles and participating in 1 clinical trial.

Locations

Nanchang, China
Other Locations
Tianjin Key Laboratory Of Risk Assessment And Control Technology For Environment And Food Safety, Tianjin, 300050, China
Key Laboratory Of Marine Chemistry Theory And Technology, Qingdao, 266100, China
Beijing, China
Jinan, China
Jining, China
P.R. China, Jining, 272100, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Prospective, Randomized, Open, Multi-center Phase III Clinical Study Comparing Efficacy and Safety of Sequential T-FEC and TX-XEC as Post-operative Adjuvant Chemotherapy Options for the Treatment of Triple-negative Breast Cancer
A Prospective, Randomized, Open, Multi-center Phase III Clinical Study Comparing Efficacy and Safety of Sequential T-FEC and TX-XEC as Post-operative Adjuvant Chemotherapy Options for the Treatment of Triple-negative Breast Cancer
Enrollment Status: Unknown
Publish Date: April 19, 2017
Intervention Type: Drug
Study Drugs: 5-Fu/Epirubicin/CTX Following Docetaxel, Docetaxel/Capecitabine Followed by Capecitabine/Epirubicin/Cyclophosphamide
Study Phase: Phase 3

39 Total Publications

ASO Visual Abstract: Predictors of Pathological Complete Response to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer-Development and Validation of a Clinical-Inflammatory Nomogram.
ASO Visual Abstract: Predictors of Pathological Complete Response to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer-Development and Validation of a Clinical-Inflammatory Nomogram.
Journal: Annals of surgical oncology
Published: March 10, 2026

Frequently Asked Questions about Yali Z. Cao

Is Yali Z. Cao a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Yali Z. Cao is classified as an Experienced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yali Z. Cao participate in research or clinical trials?

Yes. Yali Z. Cao has published 39 articles and abstracts on conditions like Breast Cancer. You can view a list of Yali Z. Cao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Cao's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile